Lineage Cell Therapeutics Sector comparison
리니지 셀 테라퓨틱스NYSEAMERICAN:LCTX · NYSE Amex · Healthcare · sector #13$0.9274-0.31%
2026-10-05 closeLineage Cell Therapeutics's close-price date is 2026-10-05. Trailing 12 months PER is -7.5×. Latest quarter PBR is 4.06×. The comparison sector is Healthcare.
Sector grades
C+
Overall: Healthcare 456/741 · top 61%
Factor composite · relative position in sector
Valuation bands — last annual report
The four key numbers use trailing earnings and the latest quarterly book value when available. These bands use the last annual report, so the values can differ.
PER — · PBR 2.73 — own-history percentile 57/100 · 72/100
Open self-history band
PER57/100
PBR72/100
Factual information · not investment advice
Quantus Signal · live data · not investment advice · Privacy Policy